All In MedTech

Device Trial Radar · NCT05633316

Automated Intracytoplasmic Sperm Injection (ICSIA)

Paired Non Inferiority Study Comparing Overture's Intracytoplasmic Sperm Injection Automated (ICSIA) System to the Standard Manual ICSI Process

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

6

Actual

Start

Nov 1, 2021

Primary completion

Mar 31, 2022

Study completion Jun 30, 2022

Sponsor

Lead sponsor
Overture LifeNot on our public-company list
Sponsor type
Industry
Collaborators
New Hope Fertility Center
First posted
Dec 1, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this research study is to evaluate Overture's automated Intracytoplasmic Sperm Injection (ICSIA) System. ICSIA is an investigational medical device that automates injection of sperm into eggs. This study will evaluate survival and fertilization rates of oocytes handled via ICSIA and compare to survival and fertilization rates of oocytes which are manually injected with sperm.

Conditions

  • Infertility, Female

Interventions

  • Investigational device named ICSIADevice

    Oocytes will undergo intracytoplasmic sperm injection using the ICSIA (the investigational) device.

  • Manual ICSIDevice

    Oocytes will undergo intracytoplasmic sperm injection using the ICSI manual protocol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical feasibility of ICSIA: oocyte survival after automated sperm injectionTime frame: Between 0 hours and 2 hours post-ICSI
  2. Technical feasibility of ICSIA: correct sperm delivery (fertilization) after automated injectionTime frame: Between 16 hours and 20 hours post-ICSI

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New Hope Fertility Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.